www.fdanews.com/articles/69476-taro-to-divest-elixsure-and-kerasal-otc-products-to-alterna
Taro to Divest ElixSure and Kerasal OTC Products to Alterna
March 4, 2005
Taro Pharmaceutical Industries and its subsidiaries reported that the company has entered into multiyear agreements to divest its OTC ElixSure and Kerasal products in North America to Alterna. The agreements provide that Taro will be the exclusive manufacturer of ElixSure and Kerasal, and that Alterna will be the exclusive marketer and distributor of these proprietary OTC product lines, in the U.S., Canada and Mexico, with an option to purchase the ElixSure and Kerasal brands in North America.